All sales, delivery, intracompany delivery, or other distributions of opiates as defined in Minnesota Statutes Section, 152.02, Subd. 3-5 must be reported.
Please note, this includes codeine-containing preparations that are classed as Schedule-III controlled substances in Minnesota, as well as butorphanol and pentazocine.
Per Minnesota Statute Section, 151.066, a "unit means the individual dosage form of the particular drug product that is prescribed to the patient".
"One unit" equals one tablet, capsule, patch, syringe, milliliter, or gram.
Reportable opiates are identified by using the Federal DEA Controlled Substances List where NARC = Y and Minnesota Statutes Section 152.02, Subd. 3-5..
Please note, codeine-containing preparations that are classified as Schedule-III controlled substances in Minnesota, as well as butorphanol and pentazocine, must be reported.
If any data element submitted does not pass validation, you will be required to resubmit the entire file once you have resolved the errors. The corrected file must be given the SAME name as the original file that was submitted. Additionally, if during the final processing of the data, it is determined there are other issues with the data, you would also be required to resubmit the entire file once the errors have been resolved. Failure to submit the updated file prior to March 1, 2021, may result in being assessed a $500 a day penalty for late reporting.
In order to delete a valid entry that was submitted in error, enter zero for the quantity and resubmit the file using the same file name as the original. Please note, the Action Indicator is not used.